For Healthcare Professionals - United States

TAVR

Transcatheter Aortic Valve Replacement

Built on the Proven Foundation of the CoreValve Platform

More than 75,000 Implants Worldwide

Proven Foundation

The CoreValve System continues to demonstrate exceptional outcomes–and we’ve taken what we’ve learned from the design of that platform and applied it to the Evolut R System.

Supra-annular Animation

Supra-annular Valve Position

The supra-annular leaflet position optimizes orifice area and flow while preserving circularity and optimal coaptation.

Self-Expanding Nitinol Frame*

The self-expanding Nitinol frame conforms and seals to the non-circular annulus. The Evolut R System has a low rate of moderate and severe PVL.

*CoreValve Evolut R Instructions for Use

 

Approved for Use in Failed Surgical Aortic Bioprosthesis

VIV InAnnulus

Over the last 10 years, the majority of surgically implanted aortic valves have been bioprosthetic. With a life expectancy of 10-20 years, the number of patients requiring redo surgery for degenerative bioprostheses is expected to increase. The CoreValve Evolut R Platform provides options for heart teams who treat patients at high operative risk for redo surgery.

Supra-Annular Design Maximizes Blood Flow
VIV Inflow The CoreValve supra-annular leaflet position—where the frame is least constrained—optimizes blood flow, maximizing the potential effective orifice area (EOA). This is critical due to previous reduction in native EOA from surgical bioprosthesis.

See Clinical Results >
 

Important Safety Information

Confidence. Delivered.